GlassScriptPhysician profile
Jeffrey E Galpin
NPI 1386679561
$1,528.70
in general payments reported to CMS, 2019-2025
21 companies · $28.30 in 2025
The $28.30 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $425 · 2020: $647 · 2021: $370 · 2023: $33.85 · 2024: $24.29 · 2025: $28.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $86.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $86.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $202.54 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $195.20 | 2019-2020 | |
| Allergan, INC. | $156.35 | 2019-2021 | |
| Gilead Sciences, INC. | $151.86 | 2019-2025 | |
| Abbvie INC. | $143.87 | 2021 | |
| Paratek Pharmaceuticals, INC. | $128.38 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $88.23 | 2019-2021 | |
| Lilly USA, LLC | $86.58 | 2019-2020 | |
| Janssen Biotech, INC. | $62.37 | 2019-2020 | |
| Pfizer INC. | $51.25 | 2020-2021 | |
| Genentech, INC. | $39.95 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $39.20 | 2019 | |
| Upsher-Smith Laboratories LLC | $36.73 | 2020-2021 | |
| Amgen INC. | $27.80 | 2020 | |
| Endo Pharmaceuticals INC. | $21.81 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $20.01 | 2019 | |
| Shionogi INC | $17.47 | 2021 | |
| Insmed, INC. | $16.24 | 2020 | |
| Glaxosmithkline, LLC. | $15.27 | 2020 | |
| Astellas Pharma US INC | $14.09 | 2020 | |
| Lupin INC. | $13.50 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Galpin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.